Why now? Polls point out that seventy four% of usa citizens can't manage their medications, and Trump faces force to lower inflation and health treatment costs. The drug marketplace is characterised by counterproductive incentives, inefficiencies and anti-competitive practices that obstruct healthy price cutting war.John Rother, AARP’s Plan an